Integrated Biopharma CFO Dina Masi's 2024 pay rises 8% to $357K
Integrated Biopharma reports 2024 executive compensation
By ExecPay News
Published: October 28, 2024
Integrated Biopharma reported fiscal year 2024 executive compensation information on October 28, 2024.
In 2024, three executives at Integrated Biopharma received on average a compensation package of $348K, a 20% increase compared to previous year.
Average pay of disclosed executives at Integrated Biopharma
Dina Masi, Chief Financial Officer, received $357K in total, which increased by 8% compared to 2023. 78% of Masi's compensation, or $280K, was in salary. Masi also received $6.3K in bonus, $60K in option awards, as well as $11K in other compensation.
Christina Kay, Chief Executive Officer, received a compensation package of $344K, which increased by 14% compared to previous year. 78% of the compensation package, or $268K, was in salary.
Riva Sheppard, Chief Executive Officer, earned $344K in 2024, a 12% increase compared to previous year.
Integrated Biopharma's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 28, 2024.